ENDRA Life Sciences Inc.

NDRA | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.31

+$0.81 (+14.73%)

At close: Sep 21, 2026, 4:00 PM ET

$6.38

+$0.07 (+1.09%)

Pre-market: Sep 22, 2026, 7:22 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-7.03M	-11.51M	-10.06M	-13.18M	-11.23M	-11.73M
Depreciation & Amortization	157.29K	206.17K	275.45K	234.26K	224.42K	165.25K
Stock-Based Compensation	329.41K	571.92K	996.43K	1.2M	1.44M	2.1M
Other Working Capital	-90.67K	97.22K	-239.11K	222.8K	-566.44K	-1.07M
Other Non-Cash Items	1.34M	3.2M	162.91K	1.39K	-298.73K	2.33M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	-2.1M
Change in Working Capital	22.62K	134.08K	-923.32K	-1.03M	-1.26M	-1.55M
Operating Cash Flow	-5.18M	-7.4M	-9.55M	-12.77M	-11.12M	-10.77M
Capital Expenditures	-17.28K	-16K	-33.88K	-202.58K	-45K	-51.33K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-3M	3.2K	9.16K	n/a	n/a	n/a
Investing Cash Flow	-3.02M	-12.8K	-24.72K	-202.58K	-45K	-51.33K
Debt Repayment	n/a	-28.48K	n/a	n/a	n/a	337.08K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	-5.23K	-840	-7.79K	-121.07K	-395.55K
Other Financial Acitivies	n/a	1	1.04M	n/a	2.91M	5.15M
Financial Cash Flow	5.73M	7.81M	7.52M	8.4M	13.4M	11.88M
Net Cash Flow	-2.47M	395.57K	-2.06M	-4.57M	2.23M	1.05M
Free Cash Flow	-5.2M	-7.42M	-9.58M	-12.97M	-11.17M	-10.82M
Adj. Free Cash Flow	-5.53M	-7.99M	-10.58M	-14.17M	-12.61M	-12.92M
Maintenance CapEx	-17.28K	-16K	-33.88K	-202.58K	-45K	-51.33K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-5.2M	-7.42M	-9.58M	-12.97M	-11.17M	-10.82M